Ignite Creation Date:
2024-05-06 @ 1:23 PM
Last Modification Date:
2024-10-26 @ 1:13 PM
Study NCT ID:
NCT04009499
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-24
First Post:
2019-07-02
Brief Title:
A Study to Assess the Long-term Safety Tolerability and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-13
Start Date Type:
ACTUAL
Primary Completion Date:
2026-05-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-05-25
Completion Date Type:
ESTIMATED
First Submit Date:
2019-07-02
First Submit QC Date:
July 2 2019
Study First Post Date:
2019-07-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2024-05-24
Last Update Post Date Type:
ACTUAL